Covalent organic framework-cellulose hydrogel composite dressing and preparation method thereof
By loading quercetin in covalent organic framework-cellulose hydrogel, the problems of insufficient hemostasis, self-healing and antibacterial properties of diabetic wound dressings are solved, and efficient wound healing and safe antibacterial effects are achieved, avoiding metals Health risks of ion accumulation.
Patent Information
- Application Number
- CN202410897797.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-05
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-07-05
AI Technical Summary
Existing diabetic wound dressings have problems with poor hemostasis, limited self-healing performance and insufficient antibacterial properties, and the use of nano-anti-bacterial metal particles may bring health risks.
Using covalent organic frame-cellulose hydrogel composite dressing, the antibacterial and healing effect of quercetin is used to bind cellulose by loading quercetin in the covalent organic frame and dispersing it in the cellulose hydrogel. The natural biocompatibility and porous structure achieve continuous release to improve antibacterial and healing effects.
Provides efficient hemostasis, promotes healing and sustained antibacterial effects while avoiding the health risks of metal ions accumulation, ensuring the biocompatibility and safety of the dressing.
Smart Images

Figure CN118987330A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical supplies, and in particular to a covalent organic framework-cellulose hydrogel composite dressing and a preparation method thereof. Background Art
[0002] The diabetic wound healing process involves complex and dynamic biological mechanisms. Traditional cotton gauze dressings, while common, suffer from poor hemostasis, limited healing-promoting properties, and excessive blood absorption. Therefore, the development of novel wound dressings with effective hemostasis, self-healing capabilities, and antimicrobial properties is crucial.
[0003] In recent years, natural hydrogels have attracted considerable research attention due to their exceptional biocompatibility, biodegradability, nontoxicity, and biomimetic properties. As functional polymer materials, hydrogels form a three-dimensional hydrophilic network structure through specific cross-linking, allowing them to swell in water without dissolving. Based on their source, hydrogels can be categorized into two main types: natural and synthetic.
[0004] Cellulose, a key raw material for natural hydrogels, possesses a rich renewable resource base and is biodegradable, regenerative, and recyclable, meeting the requirements of environmental protection and sustainable development. Compared to traditional hydrogels, cellulose-based hydrogels exhibit high water content, suitable porosity, and good cell compatibility. They can effectively provide the necessary moist environment for wounds, promoting gas exchange and exudate absorption. Furthermore, they can be easily cut into various shapes, allowing for a close fit with the wound site, enhancing self-healing effects.
[0005] It is noteworthy that the carboxyl groups in the cellulose molecular structure can bind to hemoglobin iron ions, activating coagulation factors, promoting the coagulation process, and enhancing platelet adhesion, thereby improving hemostasis. Further modification and optimization of cellulose-based hydrogels could significantly enhance their self-healing ability, cell proliferation promotion, antibacterial properties, and injectability, providing a more efficient and reliable treatment option for diabetic wound healing.
[0006] However, it must be pointed out that a single cellulose-based hydrogel itself does not usually have antibacterial activity to prevent wound infection. In order to give it antibacterial properties, antibiotics or metal ions with antibacterial activity (such as silver ions, copper ions) are usually added. However, this long-term dependence on antibiotics will lead to a large number of pathogens developing resistance to them. The consequences may affect the healing effect of the wound at the least, and may cause serious deterioration of the patient's condition or even life-threatening at the worst. Although the addition of nano-antibacterial metal particles (such as silver ions) can significantly enhance the antibacterial spectrum and antibacterial properties, the long-term accumulation of such particles in the human body may also pose health risks.
[0007] To improve the antibacterial properties of diabetic wound dressings, some innovative research has attempted to incorporate metal-organic frameworks (MOFs) into the dressings. This strategy leverages the porous structure of MOFs to effectively load antibacterial substances such as antibiotics or metal ions within their structures to achieve an antibacterial effect.
[0008] MOFs, as organic-inorganic hybrid materials, form crystalline porous materials with periodic network structures through the self-assembly of inorganic metal centers and organic ligands. Their unique properties, such as nanoscale pores, strong acid-base catalytic activity, high specific surface area, multiple metal sites, and tunable pore structure, have made them a research hotspot in materials science.
[0009] However, it's worth noting that MOFs have stability issues in aqueous solutions, with their structures prone to collapse. Furthermore, because MOFs contain metal ions at their core, long-term use can lead to metal ion accumulation and, in severe cases, even heavy metal poisoning. Therefore, these potential issues need to be addressed before further promotion and application of MOFs in diabetic wound dressings.
[0010] It can be seen that the existing technology still needs to be improved and enhanced. Summary of the Invention
[0011] In view of the above-mentioned deficiencies in the prior art, the object of the present invention is to provide a covalent organic framework-cellulose hydrogel composite dressing and a preparation method thereof, aiming to solve the problems that cellulose hydrogel does not have antibacterial properties and that MOF contains metal ions and is not suitable as a drug carrier.
[0012] In order to achieve the above object, the present invention adopts the following technical solutions:
[0013] A covalent organic framework-cellulose hydrogel composite dressing comprises a covalent organic framework with a porous structure, quercetin loaded in the pores of the covalent organic framework, and a covalent organic framework loaded with quercetin dispersed in the pores of the cellulose hydrogel; the cellulose hydrogel is used to absorb blood or tissue fluid from the wound, causing the covalent organic framework to gradually decompose and slowly release the quercetin in the pores.
[0014] The covalent organic framework-cellulose hydrogel composite dressing has a mass ratio of the covalent organic framework to quercetin of 1:(1-5); the mass of the covalent organic framework loaded with quercetin in the pores is 4% to 30% of the mass of the cellulose hydrogel.
[0015] A method for preparing a covalent organic framework-cellulose hydrogel composite dressing comprises the following steps:
[0016] S1. Synthesis of COF: A monomer containing an amino group and a monomer containing an aldehyde group are added to an organic solvent, followed by an aqueous acetic acid solution as a catalyst. The resulting solution is transferred to a hydrothermal reactor and heated for copolymerization to produce COF.
[0017] S2. Dissolving quercetin in a hot organic solvent to obtain a quercetin solution; and ultrasonically dispersing the COF obtained in step S1 into the quercetin solution, so that the quercetin is loaded into the internal pores of the COF;
[0018] S3. The quercetin-loaded COF was separated from the organic solvent by centrifugal precipitation, and then vacuum dried or naturally dried until the organic solvent was completely evaporated to obtain a quercetin-loaded COF in the pores;
[0019] S4. After dissolving the cellulose in hot water, a cellulose solution was obtained; polyvinyl alcohol was added to the cellulose solution and stirred thoroughly to obtain a cellulose / PVA mixed solution;
[0020] S5. The pores of the quercetin-loaded COF prepared in step S3 are added to the cellulose / PVA mixed solution in step S4 and mixed evenly;
[0021] S6. After removing water from the cellulose / PVA mixed solution in step S5, the covalent organic framework-cellulose hydrogel composite dressing is prepared.
[0022] The preparation method of the covalent organic framework-cellulose hydrogel composite dressing is as follows: the monomer containing an amino group is one or more of 4,4'-diaminobiphenyl, 4,4'-methylenedianiline, 1,3,5-tris(4-aminophenyl)benzene, and 4,4',4"-(1,3,5-triazine-2,4,6-triyl)triphenylamine; the monomer containing an aldehyde group is one or more of trimesic acid, 4,4',4"-(1,3,5-triazine-2,4,6-triyl)tribenzaldehyde, and 2,5-dimethoxybenzene-1,4-dicarbaldehyde; and the molar ratio of the monomer containing an amino group to the monomer containing an aldehyde group is 1:1.
[0023] The preparation method of the covalent organic framework-cellulose hydrogel composite dressing, wherein the organic solvent in step S1 is one or more of toluene, xylene, o-dichlorobenzene, trimethylbenzene, dioxane, and n-butanol.
[0024] In the method for preparing the covalent organic framework-cellulose hydrogel composite dressing, the reaction temperature of the reactor in step S1 is 80-130° C., and the reaction time is 2-7 days.
[0025] The method for preparing the covalent organic framework-cellulose hydrogel composite dressing, wherein the concentration of the acetic acid aqueous solution in step S1 is 3 mol / L or 6 mol / L.
[0026] The preparation method of the covalent organic framework-cellulose hydrogel composite dressing, wherein the organic solvent in step S2 is one of methanol, ethanol, isopropanol, acetone, ethyl acetate, and cyclohexane; and the content of the quercetin solution is 10 to 200 mg / mL.
[0027] The preparation method of the covalent organic framework-cellulose hydrogel composite dressing, wherein the dissolved cellulose concentration in step S4 is 2-10 g / 100 ml of water, and the hot water temperature is 40-65° C.; the concentration of the polyvinyl alcohol is 2-5 g / 100 ml of water.
[0028] The method for preparing the covalent organic framework-cellulose hydrogel composite dressing, wherein the operation of step S6 is specifically as follows: freezing the cellulose / PVA mixed solution in step S5 at -20°C for 24 hours, then thawing at room temperature for 4 hours, and repeating the above freezing and thawing steps three times.
[0029] Beneficial effects:
[0030] The present invention provides a preparation method of a covalent organic framework-cellulose hydrogel composite dressing, by loading the natural drug quercetin in COF and dispersing it in a cellulose-based hydrogel, it is possible to provide antibacterial properties for the cellulose-based hydrogel and promote the ability of wound healing. Moreover, quercetin is loaded in the porous structure of COF. After the cellulose hydrogel absorbs the blood / tissue fluid (pH is alkaline) of the wound, COF will gradually decompose, thereby allowing the quercetin to be continuously and slowly released, so that the hydrogel can achieve a sustained and stable antibacterial effect and the effect of promoting wound healing on the wound. Moreover, the components used in the preparation process of the cellulose-based composite hydrogel are non-toxic to cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 This is a scanning electron microscope image of the COF prepared in Example 1.
[0032] Figure 2 This is a transmission electron microscope image of the COF prepared in Example 1; the right image is an enlarged image in the red frame of the left image.
[0033] Figure 3 This is the X-ray element distribution energy spectrum of the COF material prepared in Example 1.
[0034] Figure 4 This is a graph showing the specific surface area (BET) test data of the COF material prepared in Example 1.
[0035] Figure 5 Schematic diagram of cellulose / PVA hydrogel prepared in Example 1 Figure 1 .
[0036] Figure 6 Schematic diagram of cellulose / PVA hydrogel prepared in Example 1 Figure 2 .
[0037] Figure 7 This is a scanning electron micrograph of the cellulose / PVA hydrogel prepared in Example 1.
[0038] Figure 8 Schematic diagram of the release curve of the covalent organic framework-cellulose hydrogel composite dressing prepared in Example 1 in PBS buffer at pH 7.4.
[0039] Figure 9 Schematic diagram of the antibacterial rate of Escherichia coli for the control group (COF material), cellulose / PVA hydrogel, and the covalent organic framework-cellulose hydrogel composite dressing prepared in Example 1.
[0040] Figure 10 Schematic diagram of the cell survival rate of the control group (COF material), cellulose / PVA hydrogel, cellulose / PVA hydrogel / COF (not loaded with quercetin), and the covalent organic framework-cellulose hydrogel composite dressing (1 mg / mL) prepared in Example 1 after incubation with L929 cells for 48 hours.
[0041] Figure 11 Schematic diagram of the cell survival rate of the covalent organic framework-cellulose hydrogel composite dressing prepared in Example 1 after incubation with L929 cells at different concentrations for 48 hours.
[0042] Figure 12 3 is a comparison chart of the healing effects of mouse wounds after using the control group (hydrogel prepared in Example 1) and the covalent organic framework-cellulose hydrogel composite dressing prepared in Example 1. DETAILED DESCRIPTION
[0043] The present invention provides a covalent organic framework-cellulose hydrogel composite dressing and a method for preparing the same. To clarify the objectives, technical solutions, and effects of the present invention, the present invention is further described below with reference to the accompanying drawings and examples. It should be understood that the specific examples described herein are intended only to illustrate the present invention and are not intended to limit its scope.
[0044] The present invention provides a covalent organic framework-cellulose hydrogel composite dressing, comprising a covalent organic framework with a porous structure, quercetin loaded in the pores of the covalent organic framework, and a covalent organic framework loaded with quercetin dispersed in the pores of the cellulose hydrogel; the cellulose hydrogel is used to absorb blood or tissue fluid from the wound, so that the covalent organic framework gradually decomposes and slowly releases the quercetin in the pores.
[0045] Covalent organic framework (COF) is a periodically arranged organic polymer with a certain degree of crystallinity and high porosity. The skeleton of COF is composed entirely of light elements (B, C, N, O, Si, H, etc.) connected by strong covalent bonds, such as BO, CN, BN, BO-Si, -C=N, etc. Covalent organic framework (COF) has unique properties, including metal-free organic framework, predetermined structure and pore geometry, high porosity, large surface area (from Figure 4 As shown in the specific surface area data of the COF material prepared in Example 1, its potential for easy surface modification and good biocompatibility make it an emerging porous nanomaterial in drug delivery systems. COF can be used as a drug carrier to deliver growth factors that promote cell proliferation, anti-inflammatory drugs, antibacterial drugs, and other drugs.
[0046] COF, as a crystalline porous material, has the excellent properties of MOF. Its carefully designed molecular building blocks are connected into a preset topological structure through covalent bonds, so that the COF material has better stability and regular pore structure, and has the potential for pre-functionalization and post-modification. In addition, due to the presence of a large number of imino groups in the COF molecular structure, it will be hydrolyzed into structural units under specific conditions (pH value). Therefore, non-toxic building block elements can be modified into the COF structure, so that its COF nanomaterials have the advantage of lower long-term toxicity. More importantly, since COF is formed by covalent bonds, there may be some unbonded functional groups on its matrix. The multifunctional functional groups or bonding defects on the internal channels of COF are suitable for nanocarriers through chemical functionalization or host-guest encapsulation strategies.
[0047] Using COF to load natural antibacterial extracts can not only overcome the disadvantages of antibiotics or metal ions, but also the presence of a large number of imino groups in the COF molecular structure makes it more suitable for modification, thereby loading more natural antibacterial extracts and achieving a long-term sustained release effect. Figure 3 From the X-ray element distribution spectrum of the COF material prepared in Example 1, it can be seen that the COF skeleton is entirely composed of light elements (B, C, N, O, Si, H, etc.) connected by strong covalent bonds, and it does not produce toxic substances itself.
[0048] Quercetin is a heterocyclic polyphenol flavonoid compound that can promote the proliferation of human epidermal stem cells, regulate inflammatory responses, and promote angiogenesis. It can promote skin wound healing and improve the healing quality of the epidermis by promoting the proliferation and migration of fibroblasts.
[0049] In order to solve the problem that cellulose hydrogels do not have antibacterial properties, the present invention uses a synthetic organic framework material (COF) with a porous structure as a drug carrier, and utilizes the high specific surface area and internal porous structure of COF to load quercetin, which has antibacterial and anti-inflammatory properties and can promote wound healing. Figure 7 As can be seen from the hydrogel prepared in Example 1, the hydrogel also has a porous structure, which can utilize the porous structure to adsorb blood or tissue fluid). In an alkaline environment, COF will gradually decompose, thereby slowly and continuously releasing quercetin, which can better control the release rate of quercetin. Quercetin is a natural medicine that can play an antibacterial, regulate inflammatory response, and promote angiogenesis. It can promote skin wound healing and improve the healing quality of wounds by promoting the proliferation and migration of fibroblasts. On the other hand, the quercetin molecule contains multiple phenolic hydroxyl groups, which can form hydrogen bonds with the imino groups on the COF, thereby increasing the loading capacity of the drug.
[0050] In some embodiments, the mass ratio of the covalent organic framework to quercetin is 1:(1-5). As mentioned above, quercetin is a flavonoid compound with biological activities such as antioxidant, anti-inflammatory, and wound healing. The pore structure of the COF can control the release rate of quercetin. The ideal drug release rate should match the physiological needs of the wound healing process, neither too fast nor too slow. Too fast a release may cause quercetin to be depleted in a short period of time and fail to exert its sustained effect; too slow a release rate may affect the therapeutic effect due to insufficient quercetin concentration. The pore structure, pore size, and pore shape of the COF can precisely regulate the drug release rate, thereby achieving precise treatment of the wound healing process. The COF can also achieve intelligent drug release by changing environmental factors such as pH. That is, the drug release rate is changed under specific stimuli. For example, in an alkaline wound environment, the release of quercetin is accelerated to enhance its anti-inflammatory and healing effects. However, excessive COF or quercetin concentration may cause local irritation or toxicity. The above mass ratio ensures safety and biocompatibility.
[0051] Specifically, the mass of the covalent organic framework loaded with quercetin in the pores is 4% to 30% of the mass of the cellulose hydrogel. COF serves as a carrier for quercetin, and its pore structure can control the release rate of quercetin. Cellulose hydrogel serves as the matrix of the dressing, providing a moist environment suitable for quercetin release, and its physical properties (such as viscosity, elasticity, and porosity) affect the diffusion rate of quercetin. An appropriate mass ratio can ensure that the release rate of quercetin matches the therapeutic needs, avoiding too fast or too slow release. In addition, the mixing ratio of cellulose hydrogel and COF determines the physical and mechanical properties of the composite dressing. The cellulose hydrogel gives the material flexibility and moisture retention, while the COF provides structural stability and porosity. The above ratio can ensure that the composite dressing has good adhesion, ductility, and strength, making it neither fragile nor too viscous during use, and easy to handle and use. Moreover, different mass ratios may affect the biocompatibility and safety of the composite dressing. Specifically, an excessively high COF content may increase the hardness of the composite dressing, causing discomfort or irritation to the skin, while an excessively high cellulose hydrogel content may affect the stability of the composite dressing. The above ratio helps maintain good biocompatibility and reduce potential side effects. Furthermore, either an excessively high or low ratio will affect the structural integrity of the COF and the stability of quercetin, potentially damaging the quercetin or COF structure. Furthermore, the moisturizing effect of the cellulose hydrogel can be combined with the drug delivery function of the COF to accelerate wound healing, and the above ratio maximizes this synergistic effect.
[0052] The present invention also provides a method for preparing a covalent organic framework-cellulose hydrogel composite dressing, comprising the following steps:
[0053] Synthesis of S1.COF: One or more monomers containing amino groups, such as 4,4'-diaminobiphenyl (BZD), 4,4'-methylenedianiline (MDA), 1,3,5-tris(4-aminophenyl)benzene (TAPB), and 4,4',4"-(1,3,5-triazine-2,4,6-triyl)triphenylamine (TTA), and monomers containing aldehyde groups, such as trimesic acid (TFB), 4,4',4"-(1,3,5-triazine-2,4,6-triyl)tribenzaldehyde (TTB), were added to the mixture. ), 2,5-dimethoxybenzene-1,4-dicarbaldehyde (DMTP)) are added to an organic solvent (one or more of toluene, xylene, o-dichlorobenzene, trimethylbenzene, dioxane, and n-butanol) in a molar ratio of 1:1, and then an acetic acid aqueous solution with a concentration of 3 mol / L or 6 mol / L is added as a catalyst, and the formed solution is transferred to a hydrothermal reactor (the reaction temperature of the reactor is 80-130°C, and the reaction time is 2-7 days), and heated for copolymerization to obtain COF.
[0054] The synthesis method for the COF is known as the Schiff base pathway. The amino monomer contains at least one primary or secondary amine group. The aldehyde monomer contains at least one aldehyde group (-CHO). The amino monomer and aldehyde monomer are reacted in a 1:1 molar ratio for the following reasons: 1. In a Schiff base reaction, one amino group can react with one aldehyde group to form an imine bond (Schiff base bond). Therefore, to ensure that each amino group has a corresponding aldehyde group to react, the amino and aldehyde groups should theoretically be fed in a 1:1 molar ratio. This maximizes the utilization of all reactants and reduces byproducts and unreacted raw materials. 2. The formation of a covalent organic framework (COF) relies on a regular network structure, and the formation of this structure requires that each node (i.e., monomer) can be connected to other nodes through covalent bonds. A 1:1 molar ratio ensures that each monomer has sufficient reaction sites, forming a complete three-dimensional network structure, rather than a linear or incompletely connected structure. 3. When the molar ratio deviates from 1:1, excess reactants may lead to side reactions such as polymer chain termination or excessive cross-linking, which not only reduces product purity but also may affect product yield and crystallinity. 4. A 1:1 molar ratio helps control the pore structure and size of the final COF material, which is critical to material properties such as gas adsorption, catalytic activity, and drug delivery efficiency. A precise molar ratio ensures that the COF has the desired porosity and functionalization to meet the needs of specific applications.
[0055] The aforementioned organic solvent is used to dissolve the amino and aldehyde monomers. Aqueous acetic acid, acting as a catalyst, promotes the formation of a Schiff base, accelerating COF synthesis. COF synthesis involves a Schiff base reaction, in which amino-containing monomers and aldehyde-containing monomers react through dehydration condensation to form an imine bond. Acetic acid, as a proton donor, facilitates this process by protonating the amino group, making it more receptive to reaction with the aldehyde group, accelerating Schiff base formation. As a weak acid, acetic acid provides protons, lowering the activation energy and accelerating the reaction rate. In the Schiff base reaction, the presence of acid accelerates the dehydration process and promotes imine bond formation. During the Schiff base reaction, unstable intermediates are generated. Acetic acid helps stabilize these intermediates and prevents their decomposition, thereby improving the yield and selectivity of the reaction. Aqueous acetic acid provides the acidic environment necessary for the Schiff base reaction to proceed. Furthermore, by adjusting the acetic acid concentration, the pH of the reaction environment can be fine-tuned, thereby affecting the reaction rate and direction. Aqueous acetic acid improves the polarity of the reaction medium, aiding the dissolution of the monomer in the organic solvent and ensuring uniform mixing of the reactants, thereby increasing the reaction rate. During the reaction, acetic acid can help remove byproducts, such as water, thereby driving the reaction toward the product and increasing yield.
[0056] The mixed solution is transferred to a hydrothermal reactor, a sealed container resistant to high pressure and high temperature, used to conduct chemical reactions under high-temperature and high-pressure conditions. Controlling the reaction temperature can regulate the reaction rate, reduce unnecessary side reactions, and improve the selectivity and yield of the target product. This reaction temperature is also compatible with the catalyst, accelerating the reaction. Furthermore, controlling the reaction time can achieve higher conversion rates, avoid overreaction, prevent the formation of byproducts, and improve product purity.
[0057] S2. dissolving quercetin in a hot organic solvent to obtain a quercetin solution; and ultrasonically dispersing the COF obtained in step S1 into the quercetin solution so that the quercetin is loaded into the internal pores of the COF. The solubility of quercetin in water is very low, while its solubility in organic solvents is relatively high, and the solubility of quercetin can be further improved under heating conditions. Ultrasonic dispersion can further improve the solubility of quercetin in organic solvents, accelerate the diffusion rate of quercetin in the pores of COF, and allow enough quercetin to be fully loaded in the pore structure of the COF. In addition, ultrasonic dispersion can disperse quercetin more evenly, avoid precipitation or aggregation caused by local oversaturation, and ensure more uniform drug distribution.
[0058] Specifically, the organic solvent is one of methanol, ethanol, isopropanol, acetone, ethyl acetate, and cyclohexane; the content of the quercetin solution is 10 to 200 mg / mL. The solubility of quercetin in organic solvents is limited. Too high a concentration will cause the solution to be unstable, and quercetin may precipitate to form a precipitate, which not only affects the loading efficiency but also may damage the pore structure of the COF. Controlling the concentration of the quercetin solution can optimize its loading efficiency in the COF pores. Too low a concentration may not fully utilize the pore capacity of the COF, while too high a concentration may result in too much unloaded quercetin in the solution, resulting in waste. Ultrasonic waves can accelerate the diffusion of quercetin in the COF pores, but if the quercetin content is too high, ultrasonic dispersion may not effectively promote its uniform distribution. Instead, it may cause the local concentration to be too high, affecting the integrity and stability of the COF structure.
[0059] S3. The quercetin-loaded COF is separated from the organic solvent by centrifugal precipitation, and the quercetin-loaded COF particles are separated from the organic solvent by centrifugation. The quercetin-loaded COF particles are then vacuum dried or naturally dried until the organic solvent is completely volatilized. Vacuum drying can accelerate the evaporation of the organic solvent at low temperatures, avoiding the decomposition of quercetin or destruction of the COF structure due to high temperatures. Although natural drying is slower, it can achieve the same purpose under mild conditions. Mild drying conditions help maintain the pore structure and morphology of the COF, ensuring the stability and loading efficiency of quercetin in the pores. A COF loaded with quercetin in the pores is obtained.
[0060] S4. After dissolving cellulose in hot water at a temperature of 40 to 65°C, a cellulose solution is obtained. Cellulose is almost insoluble in water at room temperature, so the solubility of cellulose in water is increased by heating. Polyvinyl alcohol is added to the cellulose solution and stirred thoroughly to obtain a cellulose / PVA mixed solution. Polyvinyl alcohol (PVA) has good solubility in water. When mixed with the cellulose solution, a certain degree of compatibility can be formed between the two, thanks to the hydrophilicity of PVA and the hydroxyl functional groups of cellulose. It should be noted that if the hot water temperature is too high, it will cause thermal degradation of PVA.
[0061] Specifically, the cellulose is dissolved at a concentration of 2-10g / 100ml of water; the polyvinyl alcohol is dissolved at a concentration of 2-5g / 100ml of water. The concentrations of cellulose and PVA need to be adjusted based on the desired material properties. Too high a concentration will result in an overly viscous solution, making it difficult to process; too low a concentration will affect the mechanical strength of the final material.
[0062] S5. The COF with quercetin loaded in the pores prepared in step S3 is added to the cellulose / PVA mixed solution in step S4 and mixed evenly.
[0063] S6. The cellulose / PVA mixed solution from step S5 is frozen at -20°C for 24 hours, then thawed at room temperature for 4 hours. The freezing and thawing steps are repeated three times to produce the covalent organic framework-cellulose hydrogel composite dressing. The purpose of removing moisture through freeze-drying cycles is to increase the material's water absorption and biocompatibility when creating a porous structure, while maintaining the activity of COF and quercetin. When the cellulose / PVA mixed solution is frozen at -20°C, the moisture forms ice crystals, which melt during the subsequent thawing process. However, since the space occupied by the ice crystals has been removed, a porous structure remains. This porous structure is crucial for hydrogel materials because it increases the material's specific surface area, improves water absorption and air permeability, and facilitates wound healing. Repeated freeze-drying cycles can optimize the material's microstructure and improve its mechanical properties. Appropriate porosity can give the material better elastic recovery under pressure while maintaining sufficient strength to support its function in the wound healing process. Freeze-drying, rather than high-temperature drying, minimizes thermal degradation of quercetin and the COF structure, ensuring their bioactivity and drug release properties in the final product. The freezing temperature is low enough to completely freeze the water while avoiding irreversible damage to the material structure caused by excessively low temperatures. Three repeated freeze-drying cycles are sufficient to form a stable porous structure while ensuring that the water in the material is fully removed. Thawing is performed at room temperature, avoiding the use of heating methods, to minimize the impact on the material structure and active ingredients.
[0064] In order to further illustrate the covalent organic framework-cellulose hydrogel and its preparation method provided by the present invention, the following examples are provided.
[0065] Example 1
[0066] A method for preparing a covalent organic framework-cellulose hydrogel comprises the following steps:
[0067] (1) Synthesis of COF: 0.3 mmol of 4,4'-diaminobiphenyl, 0.2 mmol of 4,4',4"-(1,3,5-triazine-2,4,6-triyl)triphenylamine, 0.2 mmol of 4,4',4"-(1,3,5-triazine-2,4,6-triyl)tribenzaldehyde and 0.3 mmol of 2,5-dimethoxybenzene-1,4-dicarboxaldehyde were dissolved in 10 mL of o-dichlorobenzene solution.
[0068] (2) Add 1.5 mL of 3 mol / L acetic acid aqueous solution as catalyst to the above solution and stir thoroughly.
[0069] (3) The above solution was transferred to a polytetrafluoroethylene-lined hydrothermal reactor and reacted at 110°C for 4 days.
[0070] (4) The unreacted monomers were washed with THF and DMF, and centrifuged and dried to obtain the prepared COF sample. Figure 1 Scanning electron microscope image of COF material, Figure 2 From the transmission electron microscope image of the COF material, it can be seen that the prepared COF has a uniform morphology and is spherical.
[0071] (5) Prepare a 50 mg / mL quercetin ethanol solution.
[0072] (6) 0.05 g of the COF sample prepared in step (4) was ultrasonically dispersed into 5 mL of a 50 mg / mL quercetin ethanol solution, ultrasonicated for 30 minutes, centrifuged and filtered to evaporate the ethanol, thereby obtaining a COF material with quercetin loaded in the pores.
[0073] (7) 0.8 g of cellulose was dissolved in 20 mL of hot water at 50 °C, and then 0.4 g of polyvinyl alcohol was added and stirred thoroughly to obtain a hydrogel (e.g. Figure 5 and Figure 6 As shown, the prepared hydrogel has a certain viscosity and the hydrogel will not flow even if the container is turned upside down); then 0.05 g of the COF material with quercetin loaded in the pores in step (6) is added to the hydrogel.
[0074] (8) The hydrogel was placed in a -20°C environment and frozen for 24 hours, and then thawed at room temperature for 4 hours; after the above steps were repeated 3 times, freeze-dried to remove moisture to obtain the desired covalent organic framework-cellulose hydrogel composite dressing.
[0075] from Figure 8 It can be seen that the release curve of the COF material with quercetin loaded in the pores prepared in Example 1 in PBS buffer at pH 7.4 shows that the COF material with quercetin loaded in the pores can slowly release the quercetin in the COF material between 0 and 100 hours, and can achieve a sustained and slow release of quercetin.
[0076] See also Figure 9 , Figure 9 Schematic diagram of the antibacterial rate of Escherichia coli by the control group (COF material), cellulose / PVA hydrogel, and the covalent organic framework-cellulose hydrogel composite dressing prepared in Example 1. Figure 9 It can be seen that neither the COF material nor the hydrogel alone has an antibacterial effect, while the hydrogel loaded with quercetin using the COF material can achieve an antibacterial rate of approximately 100%.
[0077] See also Figure 10 , Figure 10 This is a schematic diagram of the cell survival rate of the control group (COF material), cellulose / PVA hydrogel, cellulose / PVA hydrogel / COF (not loaded with quercetin), and the covalent organic framework-cellulose hydrogel composite dressing (1 mg / mL) prepared in Example 1 after incubation with L929 cells for 48 hours. It can be seen that the covalent organic framework-cellulose hydrogel composite dressing prepared by the present invention does not adversely affect the cell survival rate.
[0078] See also Figure 11 , Figure 11 This is a schematic diagram of the cell survival rate of the covalent organic framework-cellulose hydrogel composite dressing prepared in Example 1 after incubation with L929 cells at different concentrations for 48 hours. It can be seen that the cell survival rate gradually increases with the increase in the concentration of the hydrogel extract.
[0079] See also Figure 12 , Figure 12 This is a comparison of the wound healing effects of mice treated with the control group (hydrogel prepared in Example 1) and the covalent organic framework-cellulose hydrogel composite dressing prepared in Example 1. As can be seen from the figure, after 7 days of treatment, the wound healing effect of the mice was better than that of the control group.
[0080] Example 2
[0081] A method for preparing a covalent organic framework-cellulose hydrogel comprises the following steps:
[0082] (1) Synthesis of COF: 0.3 mmol of 4,4'-diaminobiphenyl, 0.2 mmol of 1,3,5-tris(4-aminophenyl)benzene, 0.3 mmol of trimesaldehyde and 0.2 mmol of 2,5-dimethoxybenzene-1,4-dicarbaldehyde (DMTP) were dissolved in 10 mL of xylene solution.
[0083] (2) Add 1.5 mL of 6 mol / L acetic acid aqueous solution as catalyst to the above solution and stir thoroughly.
[0084] (3) The above solution was transferred to a polytetrafluoroethylene-lined hydrothermal reactor and reacted at 90°C for 6 days.
[0085] (4) The unreacted monomers were washed with THF and DMF, and centrifuged and dried to obtain the prepared COF sample.
[0086] (5) Prepare a 50 mg / mL quercetin acetone solution.
[0087] (6) 0.05 g of the COF sample prepared in step (4) was ultrasonically dispersed into 1 mL of a 50 mg / mL quercetin acetone solution, ultrasonicated for 30 minutes, centrifuged and filtered to evaporate the ethanol, thereby obtaining a COF material with quercetin loaded in the pores.
[0088] (7) 0.8 g of cellulose was dissolved in 20 mL of hot water at 40°C, and then 0.4 g of polyvinyl alcohol was added thereto and stirred thoroughly to prepare a hydrogel; then 0.05 g of the COF material with quercetin loaded in the pores in step (6) was added to the hydrogel.
[0089] (8) The hydrogel was placed in a -20°C environment and frozen for 24 hours, and then thawed at room temperature for 4 hours; after the above steps were repeated 3 times, freeze-dried to remove moisture to obtain the desired covalent organic framework-cellulose hydrogel composite dressing.
[0090] Example 3
[0091] A method for preparing a covalent organic framework-cellulose hydrogel comprises the following steps:
[0092] (1) Synthesis of COF: 0.3 mmol of 4,4′-methylenedianiline, 0.2 mmol of 1,3,5-tris(4-aminophenyl)benzene, 0.3 mmol of 4,4′,4″-(1,3,5-triazine-2,4,6-triyl)tribenzaldehyde (TTB) and 0.2 mmol of trimesic acid were dissolved in 10 mL of n-butanol solution.
[0093] (2) Add 1.5 mL of 3 mol / L acetic acid aqueous solution as catalyst to the above solution and stir thoroughly.
[0094] (3) The above solution was transferred to a polytetrafluoroethylene-lined hydrothermal reactor and reacted at 130°C for 2 days.
[0095] (4) The unreacted monomers were washed with THF and DMF, and centrifuged and dried to obtain the prepared COF sample.
[0096] (5) Prepare a 50 mg / mL quercetin cyclohexane solution.
[0097] (6) 0.05 g of the COF sample prepared in step (4) was ultrasonically dispersed into 3 mL of a 50 mg / mL quercetin cyclohexane solution, ultrasonicated for 30 minutes, centrifuged and filtered to evaporate the ethanol, thereby obtaining a COF material with quercetin loaded in the pores.
[0098] (7) 0.8 g of cellulose was dissolved in 20 mL of hot water at 60°C, and then 0.4 g of polyvinyl alcohol was added thereto and stirred thoroughly to prepare a hydrogel; then 0.05 g of the COF material with quercetin loaded in the pores in step (6) was added to the hydrogel.
[0099] (8) The hydrogel was placed in a -20°C environment and frozen for 24 hours, and then thawed at room temperature for 4 hours; after the above steps were repeated 3 times, freeze-dried to remove moisture to obtain the desired covalent organic framework-cellulose hydrogel composite dressing.
[0100] In summary, the present invention synthesizes a series of novel COF materials formed by copolymerization of different monomers, and uses it as a drug carrier. By loading the natural drug quercetin in COF and being dispersed in a cellulose-based hydrogel, it is possible to provide antibacterial properties for the cellulose-based hydrogel, promoting the ability of wound healing. Moreover, quercetin is loaded in the porous structure of COF. After the blood / tissue fluid (pH is alkaline) of the cellulose hydrogel adsorbing the wound, COF can be progressively decomposed, thereby allowing the quercetin to be continuously and slowly released, allowing the hydrogel to achieve sustained and stable antibacterial effects and the effect of promoting wound healing on the wound. Moreover, the composition used in the preparation process of the cellulose-based composite hydrogel is non-toxic to cells.
[0101] It is understandable that those skilled in the art can make equivalent substitutions or changes based on the technical solution and inventive concept of the present invention, and all such changes or substitutions should fall within the scope of protection of the present invention.
Claims
1. A covalent organic framework-cellulose hydrogel composite dressing, characterized in that: It includes a covalent organic framework with a porous structure, quercetin loaded in the pores of the covalent organic framework, and a covalent organic framework loaded with quercetin in the pores dispersed in a cellulose hydrogel; the cellulose hydrogel is used to absorb blood or tissue fluid from a wound, so that the covalent organic framework gradually decomposes and slowly releases the quercetin in the pores.
2. The covalent organic framework-cellulose hydrogel composite dressing according to claim 1, characterized in that: The mass ratio of the covalent organic framework to quercetin is 1:(1-5); the mass of the covalent organic framework loaded with quercetin in the pores is 4%-30% of the mass of the cellulose hydrogel.
3. A method for preparing a covalent organic framework-cellulose hydrogel composite dressing, characterized in that: The steps include: S1. Synthesis of COF: A monomer containing an amino group and a monomer containing an aldehyde group are added to an organic solvent, and then an acetic acid aqueous solution is added as a catalyst, and the formed solution is transferred to a hydrothermal reactor, and heated for copolymerization to obtain COF; S2. dissolving quercetin in a hot organic solvent to obtain a quercetin solution; and ultrasonically dispersing the COF prepared in step S1 into the quercetin solution, so that the quercetin is loaded into the internal pores of the COF; S3. The quercetin-loaded COF is separated from the organic solvent by centrifugal precipitation, and then vacuum dried or naturally dried until the organic solvent is completely volatilized to obtain a quercetin-loaded COF in the pores; S4. After dissolving cellulose in hot water, a cellulose solution is obtained; polyvinyl alcohol is added to the cellulose solution and stirred to obtain a cellulose / PVA mixed solution; S5. The COF loaded with quercetin in the pores prepared in step S3 is added to the cellulose / PVA mixed solution in step S4 and mixed evenly; S6. After removing water from the cellulose / PVA mixed solution in step S5, the covalent organic framework-cellulose hydrogel composite dressing as described in any one of claims 1-2 is prepared.
4. The method for preparing the covalent organic framework-cellulose hydrogel composite dressing according to claim 3, characterized in that: The monomer containing amino groups is one or more of 4,4'-diaminobiphenyl, 4,4'-methylenedianiline, 1,3,5-tris(4-aminophenyl)benzene, 4,4',4"-(1,3,5-triazine-2,4,6-triyl)triphenylamine; the monomer containing aldehyde groups is one or more of trimesic acid, 4,4',4"-(1,3,5-triazine-2,4,6-triyl)tribenzaldehyde, 2,5-dimethoxybenzene-1,4-dicarboxaldehyde; the molar ratio of the monomer containing amino groups to the monomer containing aldehyde groups is 1:
1.
5. The method for preparing the covalent organic framework-cellulose hydrogel composite dressing according to claim 3, characterized in that: The organic solvent in step S1 is one or more of toluene, xylene, o-dichlorobenzene, trimethylbenzene, dioxane, and n-butanol.
6. The method for preparing the covalent organic framework-cellulose hydrogel composite dressing according to claim 3, characterized in that: The reaction temperature of the reactor in step S1 is 80-130° C., and the reaction time is 2-7 days.
7. The method for preparing the covalent organic framework-cellulose hydrogel composite dressing according to claim 3, characterized in that: The concentration of the acetic acid aqueous solution in step S1 is 3 mol / L or 6 mol / L.
8. The method for preparing the covalent organic framework-cellulose hydrogel composite dressing according to claim 3, characterized in that: The organic solvent in step S2 is one of methanol, ethanol, isopropanol, acetone, ethyl acetate and cyclohexane; the content of the quercetin solution is 10-200 mg / mL.
9. The method for preparing the covalent organic framework-cellulose hydrogel composite dressing according to claim 3, characterized in that: In step S4, the dissolved cellulose concentration is 2-10 g / 100 ml water, and the hot water temperature is 40-65° C.; the concentration of the polyvinyl alcohol is 2-5 g / 100 ml water.
10. The method for preparing the covalent organic framework-cellulose hydrogel composite dressing according to claim 3, characterized in that: The operation of step S6 is specifically as follows: freezing the cellulose / PVA mixed solution in step S5 at -20°C for 24 hours, and then thawing it at room temperature for 4 hours, and repeating the freezing and thawing steps three times.
Citation Information
Patent Citations
Multifunctional slow-release dressing for promoting chronic wound healing as well as preparation method and application of multifunctional slow-release dressing
CN116570760A
Fiber membrane with functions of stopping bleeding, resisting inflammation and promoting wound healing as well as preparation method and application of fiber membrane
CN116808006A
Nanocomposite, multifunctional antibacterial hydrogel as well as preparation method and application of multifunctional antibacterial hydrogel
CN117599172A
Drug sustained-release wound dressing based on natural hydrogel and preparation method of drug sustained-release wound dressing
CN117838915A
Porous cellulose-hydrogel system for enhanced transdermal delivery of flavonoids
KR1020140146745A
Cited By
Anti-inflammatory nano drug delivery system containing guanidyl structure as well as preparation method and application of anti-inflammatory nano drug delivery system
CN119235817A
